Continuous Monitoring of Right Ventricular Function, Based on the Correlation Between the C-X Segment of the Central Venous Pressure Curve, and the Echocardiographic Evaluation of Right Ventricular Systolic Function
CourbePVC
1 other identifier
observational
250
1 country
1
Brief Summary
Close analysis of right ventricular function is still not done by all clinicians, even though it is indispensable; notably in cardiovascular ICUs. Right ventricular dysfunction is responsible for increased morbidity and marks a turning point in the patient's prognosis. It is difficult to analyse, and is principally assessed using echocardiography and by measuring the peak of the S' wave with pulsed Doppler and by measuring the tricuspid annular plane systolic excursion (TAPSE) in the TM mode. New studies have shown the interest of using 2D strain as a marker of systolic and diastolic function of the right ventricle. Finally, the use of 3D ultrasound seems to be more reliable than cardiac MRI for fine analysis of the right ventricle, even though it is rarely used in routine practice. Study of the right ventricle using ultrasonography alone requires experienced and available operators for closely repeated evaluations making it possible to detect right ventricle dysfunction quickly. US monitoring of left and right heart function is done systematically and repeatedly during post-operative care following heart surgery. This US evaluation could be optimized by finding a way to monitor the right ventricle continuously. From a physiological point of view, we know about the tight relationship between the aspect of the central venous pressure curve and more precisely the C-X segment (tricuspid bulging into the atrium and start of contraction of the right ventricle) and right ventricular function. We wish to analyse this segment, combined with a US evaluation, and to look for a possible correlation so as to allow continuous, easy-to-interpret monitoring of right ventricular systolic function. This will be facilitated by the systematic presence of a central venous catheter in every patient undergoing heart surgery, thus allowing central venous pressure to be monitored. To this end, we wish to collect different data from patients in the cardiovascular ICU, especially the central venous pressure curve, the ventilatory pressure curve and settings of the respirator, and to carry out an echography evaluation of each patient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2016
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 2, 2016
CompletedFirst Submitted
Initial submission to the registry
September 25, 2017
CompletedFirst Posted
Study publicly available on registry
September 28, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 2, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 2, 2017
CompletedFebruary 28, 2023
September 1, 2017
1 year
September 25, 2017
February 27, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Measure the peak of the S' wave
At baseline
Measure the tricuspid annular plane systolic excursion (TAPSE)
At baseline
Calculate strain in the right ventricle
At baseline
Eligibility Criteria
Patients admitted to a cardiovascular ICU following heart surgery
You may qualify if:
- Patients admitted to the cardiovascular ICU
- Patients with spontaneous breathing
- With a central venous catheter placed in the internal jugular vein and for whom the central venous pressure curve is exploitable
- With a US window allowing a 4-chamber view making it possible to calculate the right ventricle ejection fraction (Peak of the S' wave, of the TAPSE, Strain of the right ventricle)
You may not qualify if:
- Non-echogenic patients or those without an exploitable US window
- Patients without a central venous catheter in the internal jugular vein
- Patients with an unexploitable central venous pressure curve
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu Dijon Bourogne
Dijon, France
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 25, 2017
First Posted
September 28, 2017
Study Start
November 2, 2016
Primary Completion
November 2, 2017
Study Completion
November 2, 2017
Last Updated
February 28, 2023
Record last verified: 2017-09